tiprankstipranks
Trending News
More News >
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market
Advertisement

Tarsus Pharmaceuticals (TARS) Revenue

Compare
251 Followers

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had a revenue of 118.70M in the quarter ending Sep 30, 2025, with 15.62%. This bring the company's revenue in the last twelve months to 366.10M, Decreased 23.88%. In the fiscal year ending Dec 31, 2024, Tarsus Pharmaceuticals had annual revenue of 182.95M with 948.62% growth.
Revenue (ttm)
366.10M
Revenue Growth
182.44%
P/S Ratio
16.92
Revenue/Employee
$566,418
Employees
323
Market Cap
$3.10B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
182.95M165.51M+1,048.62%
Dec 31, 2023
17.45M-8.37M+67.58%
Dec 31, 2022
25.82M-31.21M+45.27%
Dec 31, 2021
57.03M-5,702,700,000.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis